Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.78 HKD | +0.59% | -2.87% | +1.50% |
04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.50% | 601M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 1477 Stock
- News Ocumension Therapeutics
- China Accepts New Drug Application for Ocumension Therapeutics' Anti-Allergy Eye Drops